Utah Medical Products - 21 Year Stock Price History | UTMD

Historical daily share price chart and data for Utah Medical Products since 1999 adjusted for splits. The latest closing stock price for Utah Medical Products as of May 29, 2020 is 99.48.
  • The all-time high Utah Medical Products stock closing price was 116.00 on June 20, 2018.
  • The Utah Medical Products 52-week high stock price is 112.26, which is 12.8% above the current share price.
  • The Utah Medical Products 52-week low stock price is 75.33, which is 24.3% below the current share price.
  • The average Utah Medical Products stock price for the last 52 weeks is 93.10.
Utah Medical Products Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 89.9068 106.7600 108.5200 77.0500 99.4800 -7.80%
2019 91.6665 84.7700 109.3000 77.7600 107.9000 29.87%
2018 94.3863 79.3000 116.0000 74.6400 83.0800 2.06%
2017 69.7137 71.4000 84.0500 58.8500 81.4000 11.89%
2016 63.0624 58.6600 72.7500 55.5100 72.7500 24.27%
2015 56.5516 57.8800 62.6900 50.6300 58.5400 -2.51%
2014 53.0068 51.7600 60.1300 47.0900 60.0500 5.06%
2013 49.9361 38.3200 63.7400 38.3200 57.1600 58.56%
2012 32.6495 27.3100 36.1600 26.9800 36.0500 33.52%
2011 26.8385 26.9850 29.3000 24.5200 27.0000 0.45%
2010 27.3865 29.5600 30.2600 24.4500 26.8800 -8.32%
2009 26.0745 23.9500 30.0000 21.1100 29.3200 33.58%
2008 27.7187 29.6000 30.9000 21.1600 21.9500 -26.14%
2007 31.7939 33.0000 34.5940 29.5000 29.7200 -9.88%
2006 31.5969 30.6000 34.5000 28.5000 32.9800 3.22%
2005 23.6948 22.2100 31.9500 20.1000 31.9500 42.19%
2004 23.1344 25.7100 27.0000 17.2600 22.4700 -14.04%
2003 21.1741 19.3100 26.1400 17.5000 26.1400 36.86%
2002 15.6694 13.2000 19.2800 12.5400 19.1000 40.34%
2001 10.5207 7.5000 13.7400 7.0310 13.6100 81.47%
2000 7.1738 6.4400 8.3750 6.0000 7.5000 11.11%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.365B $0.047B
Utah Medical Products is in the business of producing cost-effective devices for the healthcare industry which are predominantly proprietary, disposable and for hospital use. The company's success in rapidly producing solutions comes from its proven ability to integrate a number of engineering and technical disciplines in electronics, software, mechanical packaging, instrumentation, optics and materials. The resulting proprietary products represent significant incremental improvementsover existing clinical techniques.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $162.911B 28.25
Medtronic (MDT) Ireland $131.524B 21.38
Stryker (SYK) United States $73.223B 23.76
Boston Scientific (BSX) United States $52.434B 24.65
Baxter (BAX) United States $44.736B 27.31
Lonza Group Ag (LZAGY) Switzerland $36.436B 0.00
Terumo (TRUMY) Japan $29.523B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $28.846B 0.00
Zimmer Biomet Holdings (ZBH) United States $26.418B 16.62
ResMed (RMD) United States $22.976B 36.26
Smith & Nephew SNATS (SNN) United Kingdom $18.348B 0.00
Sunny Optical Technology (SNPTF) China $14.583B 0.00
Bio-Rad Laboratories (BIO) United States $14.145B 64.39
Insulet (PODD) United States $11.644B 1153.63
DiaSorin S.p.A (DSRLF) Italy $10.630B 0.00
Canopy Growth (CGC) Canada $7.619B 0.00
Perrigo (PRGO) Ireland $7.501B 13.42
Shandong Weigao Medical Polymer (SHWGF) China $7.281B 0.00
Quidel (QDEL) United States $7.023B 55.19
Hill-Rom Holdings (HRC) United States $6.867B 19.36
William Demant Holdings (WILYY) Denmark $6.670B 0.00
GN STORE NORD (GNNDY) Denmark $6.590B 34.05
Haemonetics (HAE) United States $5.562B 33.41
ICU Medical (ICUI) United States $4.105B 29.95
GW Pharmaceuticals (GWPH) United Kingdom $3.879B 0.00
Neogen (NEOG) United States $3.702B 62.71
Agios Pharmaceuticals (AGIO) United States $3.675B 0.00
Envista Holdings (NVST) United States $3.334B 0.00
NuVasive (NUVA) United States $3.147B 25.27
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.829B 0.00
TG Therapeutics (TGTX) United States $2.175B 0.00
National Vision Holdings (EYE) United States $2.127B 36.81
AtriCure (ATRC) United States $1.946B 0.00
Aurora Cannabis (ACB) Canada $1.556B 0.00
Cardiovascular Systems (CSII) United States $1.386B 0.00
Aphria (APHA) Canada $1.152B 0.00
NanoString Technologies (NSTG) United States $1.134B 0.00
MacroGenics (MGNX) United States $1.130B 0.00
Phibro Animal Health (PAHC) United States $1.088B 21.69
Cerus (CERS) United States $0.997B 0.00
InMode (INMD) Israel $0.915B 19.33
PetIQ (PETQ) United States $0.863B 24.93
OraSure Technologies (OSUR) United States $0.839B 168.88
Omeros (OMER) United States $0.826B 0.00
Quanterix (QTRX) United States $0.764B 0.00
VAREX IMAGING (VREX) United States $0.741B 18.39
DFB Healthcare Acquisitions (AHCO) United States $0.738B 124.92
Eagle Pharmaceuticals (EGRX) United States $0.711B 50.90
Zynex (ZYXI) United States $0.628B 63.10
Meridian Bioscience (VIVO) United States $0.607B 22.87
Lantheus Holdings (LNTH) United States $0.569B 11.44
LeMaitre Vascular (LMAT) United States $0.546B 31.10
Vapotherm (VAPO) United States $0.541B 0.00
Surmodics (SRDX) United States $0.524B 63.13
Owens & Minor (OMI) United States $0.488B 12.92
Repro-Med Systems (KRMD) United States $0.379B 318.33
Cytosorbents (CTSO) United States $0.350B 0.00
BioLife Solutions (BLFS) United States $0.340B 151.09
Organigram Holdings (OGI) Canada $0.329B 0.00
Viemed Healthcare (VMD) United States $0.308B 27.59
Neptune Wellness Solutions (NEPT) Canada $0.280B 0.00
HEXO (HEXO) $0.278B 0.00
Female Health (VERU) United States $0.247B 0.00
InfuSystems Holdings (INFU) United States $0.219B 121.22
Chimerix (CMRX) United States $0.197B 0.00
Evolus (EOLS) United States $0.179B 0.00
Chembio Diagnostics (CEMI) United States $0.157B 0.00
Fonar (FONR) United States $0.154B 13.63
Bovie Medical (APYX) United States $0.151B 0.00
Rockwell Medical (RMTI) United States $0.148B 0.00
Exagen (XGN) United States $0.146B 0.00
Surface Oncology (SURF) United States $0.138B 0.00
MTech Acquisition (KERN) United States $0.137B 0.00
Liberty Health Sciences (LHSIF) Canada $0.135B 0.00
United Health Products (UEEC) United States $0.133B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.115B 0.00
Brainsway (BWAY) Israel $0.085B 0.00
Wound Management Technologies (SMTI) United States $0.078B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.076B 0.00
United-Guardian (UG) United States $0.076B 17.51
Nephros (NEPH) United States $0.070B 0.00
Capricor Therapeutics (CAPR) United States $0.062B 0.00
GUARDION HEALTH (GHSI) United States $0.045B 0.00
ImmuCell (ICCC) United States $0.031B 0.00
Trinity Biotech (TRIB) Ireland $0.031B 0.00
NF Energy Saving (BIMI) China $0.025B 0.00
FSD PHARMA INC (HUGE) Canada $0.021B 0.00
Akers Biosciences Inc (AKER) United States $0.016B 0.00
Myomo (MYO) United States $0.011B 0.00
Senestech (SNES) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00